Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The imidazoline-preferring receptor.

J Lehmann1, E Koenig-Bérard, P Vitou

  • 1Institut de Recherches Internationales Servier Neuilly sur Seine, France.

Life Sciences
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recellularization of auricular cartilage via elastase-generated channels.

Biofabrication·2019
Same author

Constraining the p-Mode-g-Mode Tidal Instability with GW170817.

Physical review letters·2019
Same author

Search for Subsolar-Mass Ultracompact Binaries in Advanced LIGO's First Observing Run.

Physical review letters·2018
Same author

GW170817: Measurements of Neutron Star Radii and Equation of State.

Physical review letters·2018
Same author

Search for Tensor, Vector, and Scalar Polarizations in the Stochastic Gravitational-Wave Background.

Physical review letters·2018
Same author

[Is there also a gynecologist for men? : A randomised controlled trial of ÄGGF information sessions in schools as a bridge to the urologist's consultations with boys].

Der Urologe. Ausg. A·2018
Same journal

Corrigendum to "Adipose stem cells-derived microvesicles and chicken egg-derived exosomes attenuate cardiac ischemia/reperfusion injury through AKT/ERK/Nrf2/HO-1 axis to inhibit apoptosis and inflammation and restore autophagy" [Life Sci. 395 (2026) 124364].

Life sciences·2026
Same journal

MAGED1 stabilizes NEUROD1 to promote Per3 expression in the pineal gland.

Life sciences·2026
Same journal

TNF-centered network pharmacology and molecular modeling of selected Andrographis paniculata compounds in hypertension.

Life sciences·2026
Same journal

Retraction notice to "Beneficial effect of Calculus Bovis Sativus on 17α-ethynylestradiol-induced cholestasis in the rat" [Life Sci. 113 (2014) 22-30].

Life sciences·2026
Same journal

Soluble PD-1 drives renal fibrosis in CKD by disrupting immune homeostasis: Therapeutic mitigation via a targeted sPD-1 sequestration strategy.

Life sciences·2026
Same journal

METTL1 promotes hepatic steatosis by mediating m<sup>7</sup>G modification of ALOX15B mRNA.

Life sciences·2026
See all related articles

New evidence suggests alpha 2-adrenoceptors have subtypes. One subtype, the imidazoline-preferring receptor (IPR), differs pharmacologically and molecularly from traditional alpha 2-adrenoceptors, impacting drug development.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Molecular Biology

Background:

  • Over the past decade, research has increasingly supported the existence of alpha 2-adrenoceptor subtypes.
  • A distinct receptor, the imidazoline-preferring receptor (IPR), shares similarities with alpha 2-adrenoceptors but exhibits unique binding properties.

Purpose of the Study:

  • To differentiate between alpha 2-adrenoceptors and imidazoline-preferring receptors (IPRs).
  • To highlight the distinct pharmacological, anatomical, and molecular characteristics of these receptor subtypes.

Main Methods:

  • In vitro physiological studies
  • Radioligand binding assays
  • Comparative analysis of agonist and antagonist profiles

Main Results:

Related Experiment Videos

  • IPRs are largely insensitive to catecholamines but bind selectively to imidazolines and oxazolines (e.g., idazoxan, rilmenidine).
  • Alpha 2-adrenoceptors are preferentially activated by catecholamines (e.g., alpha-methylnorepinephrine, epinephrine) and antagonized by rauwolscine.
  • Significant differences in anatomical distribution and molecular properties exist between IPRs and alpha 2-adrenoceptors.

Conclusions:

  • The findings provide strong evidence for distinct alpha 2-adrenoceptor subtypes.
  • These receptor subtypes possess unique pharmacological profiles, distribution, and molecular characteristics.
  • Ongoing research is extending these findings from in vitro to in vivo and clinical studies, with implications for therapeutic strategies.